miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Human Molecular Genetics

• Publication date

  2015-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/hmg/ddv377PMID 26362250PMCID PMC4634376
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Depressive Symptoms

  2017cited by this paper
• Early etiology of Alzheimer’s disease: tipping the balance toward autophagy or endosomal dysfunction?

  2015cited by this paper
• Memory formation and retention are affected in adult miR-132/212 knockout mice.

  2015influential reference
• mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy.

  2015cited by this paper
• MicroRNA‐138 promotes tau phosphorylation by targeting retinoic acid receptor alpha

  2015cited by this paper
• Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau.

  2015cited by this paper
• The biological functions of miRNAs: lessons from in vivo studies.

  2015cited by this paper
• The gene silencing transcription factor REST represses miR-132 expression in hippocampal neurons destined to die.

  2014cited by this paper
• MicroRNAs targeting Nicastrin regulate Aβ production and are affected by target site polymorphisms

  2014cited by this paper
• Motor neuron disease and frontotemporal dementia: sometimes related, sometimes not.

  2014cited by this paper
• MicroRNAs in brain development and function: a matter of flexibility and stability

  2014cited by this paper
• Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels

  2014cited by this paper
• Models of β-amyloid induced Tau-pathology: the long and “folded” road to understand the mechanism

  2014cited by this paper
• Rare autosomal copy number variations in early-onset familial Alzheimer’s disease

  2014cited by this paper
• Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition.

  2014cited by this paper
• Interaction of transactive response DNA binding protein 43 with nuclear factor κB in mild cognitive impairment with episodic memory deficits

  2014cited by this paper
• MicroRNA‐125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease

  2014cited by this paper
• Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52

  2014cited by this paper
• MicroRNA-922 promotes tau phosphorylation by downregulating ubiquitin carboxy-terminal hydrolase L1 (UCHL1) expression in the pathogenesis of Alzheimer's disease.

  2014cited by this paper
• Huntington's disease is a four-repeat tauopathy with tau nuclear rods

  2014cited by this paper
• miR-132/212 Knockout Mice Reveal Roles for These miRNAs in Regulating Cortical Synaptic Transmission and Plasticity

  2013cited by this paper
• Plasma microRNA biomarkers for detection of mild cognitive impairment: Biomarker Validation Study

  2013cited by this paper
• Identification of Differentially Expressed MicroRNAs Across the Developing Human Brain

  2013cited by this paper
• The role of autophagy in neurodegenerative disease

  2013cited by this paper
• A Study of Small RNAs from Cerebral Neocortex of Pathology-Verified Alzheimer's Disease, Dementia with Lewy Bodies, Hippocampal Sclerosis, Frontotemporal Lobar Dementia, and Non-Demented Human Controls

  2013cited by this paper
• mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies

  2013cited by this paper
• Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis

  2013cited by this paper
• In vivo knockdown of hippocampal miR‐132 expression impairs memory acquisition of trace fear conditioning

  2013cited by this paper
• De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease.

  2013cited by this paper
• Alternative polyadenylation and miR‐34 family members regulate tau expression

  2013cited by this paper
• Alteration of the microRNA network during the progression of Alzheimer's disease

  2013cited by this paper
• Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice

  2013cited by this paper
• Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice.

  2013cited by this paper
• MicroRNAs and neurodegeneration: role and impact.

  2013cited by this paper
• Deregulation of Protein Phosphatase 2A and Hyperphosphorylation of τ Protein Following Onset of Diabetes in NOD Mice

  2013cited by this paper
• Early Increases in Soluble Amyloid-β Levels Coincide with Cholinergic Degeneration in 3xTg-AD Mice

  2012cited by this paper
• The downward spiral of tau and autolysosomes

  2012cited by this paper
• MicroRNAs in Alzheimer's disease.

  2012cited by this paper
• miR-212/132 expression and functions: within and beyond the neuronal compartment

  2012cited by this paper
• Copy number variations involving the microtubule-associated protein tau in human diseases.

  2012cited by this paper
• The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy

  2012cited by this paper
• TMEM106B, the Risk Gene for Frontotemporal Dementia, Is Regulated by the microRNA-132/212 Cluster and Affects Progranulin Pathways

  2012cited by this paper
• Propagation of tau pathology in a model of early Alzheimer's disease.

  2012cited by this paper
• Gene Network and Pathway Analysis of Mice with Conditional Ablation of Dicer in Post-Mitotic Neurons

  2012cited by this paper
• Plasma microRNA biomarkers for detection of mild cognitive impairment

  2012cited by this paper
• MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function

  2012cited by this paper
• The cholinergic system in aging and neuronal degeneration.

  2011cited by this paper
• Altered microRNA regulation in Huntington's disease models.

  2011cited by this paper
• O4‐06‐06: 48‐week efficacy and tolerability of treatment with SB‐742457, a novel 5HT6 receptor antagonist, when added on to donepezil in subjects with mild‐to‐moderate Alzheimer's disease (AD)

  2011cited by this paper
• Patterns of microRNA expression in normal and early Alzheimer’s disease human temporal cortex: white matter versus gray matter

  2011cited by this paper
• microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus

  2010influential reference
• Regulation of the miR-212/132 locus by MSK1 and CREB in response to neurotrophins.

  2010cited by this paper
• Preparation of mouse brain tissue for immunoelectron microscopy.

  2010cited by this paper
• Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation and myelination.

  2010cited by this paper
• Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration.

  2010influential reference
• MicroRNA132 Modulates Short-Term Synaptic Plasticity but Not Basal Release Probability in Hippocampal Neurons

  2010cited by this paper
• Desperately seeking microRNA targets

  2010cited by this paper
• Frontotemporal Dementia Phenotype Associated with MAPT Gene Duplication

  2010cited by this paper
• Drug Development Research

  2009cited by this paper
• Ago HITS-CLIP decodes miRNA-mRNA interaction maps

  2009cited by this paper
• MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase.

  2009cited by this paper
• Partial deletion of the MAPT gene: A novel mechanism of FTDP‐17

  2009cited by this paper
• Dietary composition modulates brain mass and solubilizable Aβ levels in a mouse model of aggressive Alzheimer's amyloid pathology

  2009cited by this paper
• MicroRNA regulation of Alzheimer's Amyloid precursor protein expression.

  2009cited by this paper
• Tau exon 10 alternative splicing and tauopathies

  2008cited by this paper
• Decreased drebrin mRNA expression in Alzheimer disease: Correlation with tau pathology

  2008cited by this paper
• An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP

  2008cited by this paper
• Animal models of Alzheimer's disease and frontotemporal dementia

  2008cited by this paper
• Tau as a biomarker of neurodegenerative diseases.

  2008cited by this paper
• Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways

  2008cited by this paper
• Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression

  2008cited by this paper
• Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease.

  2007cited by this paper
• Biochemical Characterization of Aβ and Tau Pathologies in Mild Cognitive Impairment and Alzheimer's Disease

  2007cited by this paper
• Biomedicine & Diseases: Review RNA and protein-dependent mechanisms in tauopathies: consequences for therapeutic strategies

  2007cited by this paper
• miRNAs in Neurodegeneration

  2007cited by this paper
• The H1c haplotype at the MAPT locus is associated with Alzheimer's disease.

  2005cited by this paper
• A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis.

  2005cited by this paper
• Tau protein as a differential biomarker of tauopathies.

  2005cited by this paper
• Alterations in Glucose Metabolism Induce Hypothermia Leading to Tau Hyperphosphorylation through Differential Inhibition of Kinase and Phosphatase Activities: Implications for Alzheimer's Disease

  2004cited by this paper
• Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation

  2004cited by this paper
• Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.

  2003cited by this paper
• The mouse brain in stereotaxic coordinates

  2003cited by this paper
• Disentangling the pathology of schizophrenia and paraphrenia

  2002cited by this paper
• Depressive symptoms, cognitive decline, and risk of AD in older persons

  2002cited by this paper
• Role of GSK‐3β in Alzheimer's disease pathology

  2002cited by this paper
• Tau protein isoforms, phosphorylation and role in neurodegenerative disorders.

  2000cited by this paper
• Conformational change as one of the earliest alterations of tau in Alzheimer's disease.

  2000cited by this paper
• Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes.

  2000cited by this paper
• REVIEW: tau protein pathology in Alzheimer’s disease and related disorders

  1999cited by this paper
• Tau protein pathology in neurodegenerative diseases.

  1998cited by this paper
• Alz‐50 and MC‐1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau

  1997cited by this paper
• Monoclonal antibody PHF‐1 recognizes tau protein phosphorylated at serine residues 396 and 404

  1994cited by this paper
• LUCOCORTICOID ATTENUATES BRAIN-DERIVED NEUROTROPHIC ACTOR-DEPENDENT UPREGULATION OF GLUTAMATE RECEPTORS IA THE SUPPRESSION OF MICRORNA-132 EXPRESSION

  year unknowncited by this paper

• Current potential biomarkers for Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis: review of literature

  2026cites this paper
• Morpho-Functional Characterization and miRNA Profiling of the Retina in the 5xFAD Murine Model of Alzheimer's Disease

  2026cites this paper
• The Expanding Role of Non-Coding RNAs in Neurodegenerative Diseases: From Biomarkers to Therapeutic Targets

  2026cites this paper
• Differentially expressed miRNAs in the temporal cortex of Alzheimer’s disease patients and their association to tau pathology

  2026cites this paper
• Unlocking the Therapeutic Promise of miRNAs in Promoting Amyloid-β Clearance for Alzheimer's Disease.

  2025cites this paper
• MicroRNAs in neurodegenerative diseases: from molecular mechanisms to clinical biomarkers, detection methods and therapeutic strategies—advances and challenges

  2025cites this paper
• An Update on Neuroaging on Earth and in Spaceflight

  2025cites this paper
• Exploring the Role of microRNAs as Blood Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia

  2025cites this paper
• Critical role of microRNAs in cellular quality control during brain aging and neurological disorders: Interplay between autophagy and proteostasis.

  2025cites this paper
• MicroRNAs modulation by curcumin, catalpol, and other natural products in Alzheimer’s disease: a review

  2025cites this paper
• Exosomal Non-Coding RNAs as Potential Biomarkers for Alzheimer’s Disease: Advances and Perspectives in Translational Research

  2025cites this paper
• The emerging role of miRNAs in biological aging and age-related diseases

  2025cites this paper
• Epigenetics Modulators as Therapeutics for Neurological Disorders.

  2025cites this paper
• Direct and indirect role of non-coding RNAs in company with amyloid and tau protein in promoting neuroinflammation in post-ischemic brain neurodegeneration

  2025cites this paper
• Insights From a Scoping Review and Bibliometric Analysis of Trends and Advances in Biomarker Research: The Role of MicroRNAs in Cognitive Decline Across Neurodegenerative Diseases

  2025cites this paper
• MicroRNA-132 regulates quinolinic acid production in the brain during LPS-induced neuroinflammation

  2025cites this paper
• Circular RNAs, miRNAs, and Exosomes: Their Roles and Importance in Amyloid-Beta and Tau Pathologies in Alzheimer's Disease

  2025cites this paper
• Insilico and Invivo protective effect of biochanin-A mitigating doxorubicin- induced cognitive deficits and neuroinflammation: Insights to the role of p-Tau and miR-132.

  2025cites this paper
• Understanding the Molecular Basis of Miller–Dieker Syndrome

  2025cites this paper
• Non-coding RNAs in the pathogenesis of Alzheimer’s disease: β-amyloid aggregation, Tau phosphorylation and neuroinflammation

  2025cites this paper
• MicroRNA‐microbiota interactions: Emerging strategies for modulating intestinal homeostasis and enhancing host health

  2025cites this paper
• Exercise-induced modulation of miRNAs and gut microbiome: a holistic approach to neuroprotection in Alzheimer’s disease

  2025cites this paper
• Aryl Hydrocarbon Receptor Establishes a Delicate Balance between the Level of the Trace Amine Tryptamine and Monoamine Oxidase Activity in the Brain and Periphery in Health and Conditions such as Neurodegenerative, Neurodevelopmental, and Psychiatric Disorders

  2025cites this paper
• Extracellular microRNAs modulate human microglial function through TLR8

  2025influential citation
• Unraveling the Significance of Fecal MicroRNA Profile in Alzheimer’s Disease

  2025cites this paper
• NACC2, a molecular effector of miR-132 regulation at the interface between adult neurogenesis and Alzheimer’s disease

  2024cites this paper
• Exploring the Regulatory Landscape of Dementia: Insights from Non-Coding RNAs

  2024cites this paper
• Downregulation of hsa-miR-132 and hsa-miR-129: non-coding RNA molecular signatures of Alzheimer’s disease

  2024cites this paper
• Extracellular vesicle-packed microRNAs profiling in Alzheimer's disease: The molecular intermediary between pathology and diagnosis.

  2024cites this paper
• REGULATORY ROLES OF microRNAs IN MODULATING MITOCHONDRIAL DYNAMICS, AMYLOID BETA FIBRILLATION, MICROGLIAL ACTIVATION, AND CHOLINERGIC SIGNALING: IMPLICATIONS FOR ALZHEIMER'S DISEASE PATHOGENESIS.

  2024cites this paper
• The Potential of Targeting Autophagy-Related Non-coding RNAs in the Treatment of Alzheimer’s and Parkinson’s Diseases

  2024cites this paper
• Epigenetic Biomarkers in Alzheimer's Disease: Diagnostic and Prognostic Relevance.

  2024cites this paper
• [Expression relationship and significance of NEAT1 and miR-27a-3p in serum and cerebrospinal fluid of patients with Alzheimer disease].

  2024cites this paper
• RNA: The Unsuspected Conductor in the Orchestra of Macromolecular Crowding

  2024cites this paper
• Noncoding RNAs in Alzheimer's Disease: Overview of Functional and Therapeutic Significance.

  2024cites this paper
• The regulation of miRNAs using curcumin and other polyphenols during the prevention and treatment of Alzheimer's disease.

  2024cites this paper
• In vivo and ex vivo gene therapy for neurodegenerative diseases: a promise for disease modification

  2024cites this paper
• Beneficial effects of miR-132/212 deficiency in the zQ175 mouse model of Huntington’s disease

  2024cites this paper
• Potential mechanisms of non-coding RNA regulation in Alzheimer’s disease

  2024influential citation
• Mapping the current trends and hotspots of extracellular vesicles in Alzheimer's disease: a bibliometric analysis

  2024cites this paper
• Exosomal MicroRNAs in Alzheimer’s Disease: Unveiling Their Role and Pioneering Tools for Diagnosis and Treatment

  2024cites this paper
• Effects of MicroRNAs and Long Non-coding RNAs on Beneficial Action of Exercise on Cognition in Degenerative Diseases: A Review

  2024cites this paper
• A role for astrocytic miR-129-5p in frontotemporal dementia

  2024cites this paper
• Ageing at Molecular Level: Role of MicroRNAs.

  2023cites this paper
• Non-coding RNAs in Regulation of Protein Aggregation and Clearance Pathways: Current Perspectives Towards Alzheimer's Research and Therapy.

  2023cites this paper
• Hypoxia Inhibits Cell Cycle Progression and Cell Proliferation in Brain Microvascular Endothelial Cells via the miR-212-3p/MCM2 Axis

  2023cites this paper
• Pathogenesis of miR-155 on nonmodifiable and modifiable risk factors in Alzheimer’s disease

  2023cites this paper
• The role of microRNAs in neurobiology and pathophysiology of the hippocampus

  2023cites this paper
• MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis.

  2023cites this paper
• TRP channels: Role in neurodegenerative diseases and therapeutic targets

  2023cites this paper
• Discerning the Prospects of miRNAs as a Multi-Target Therapeutic and Diagnostic for Alzheimer’s Disease

  2023cites this paper
• MicroRNA-125a-3p modulate amyloid β-protein through the MAPK pathway in Alzheimer's disease.

  2023cites this paper
• MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer’s Disease

  2023cites this paper
• Effect of Linalool, Cineole, and β-Bourbonene Coupled with Aerobic Training on the Improvement of Presenilin-1/Amyloid Protein Precursor/Interleukin-1 beta/CASPASE 1 Network, Oxidative Capacity, and miRNA-210 in Mice with Alzheimer's Disease.

  2023cites this paper
• microRNA-132 regulates gene expression programs involved in microglial homeostasis

  2023cites this paper
• MicroRNAs as Possible Biomarkers for Diagnosis and Therapy of Alzheimer’s Disease by Regulating the Abnormal Expression of Genes Related to Tau

  2023cites this paper
• Sexually dimorphic age‐related molecular differences in the entorhinal cortex of cognitively intact elderly: Relation to early Alzheimer's changes

  2023cites this paper
• Targeting epigenetics: A novel promise for Alzheimer's disease treatment.

  2023cites this paper
• Small molecule regulators of microRNAs identified by high-throughput screen coupled with high-throughput sequencing

  2023cites this paper
• 靶向微RNA的阿尔茨海默病防治研究进展

  2023cites this paper
• Effect of trehalose on miR-132 and SIRT1 in the hippocampus of aged rats.

  2023cites this paper
• Reappraisal of the Concept of Accelerated Aging in Neurodegeneration and Beyond

  2023cites this paper
• miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer’s Disease

  2023cites this paper
• Mechanisms of microRNA-132 in central neurodegenerative diseases: A comprehensive review.

  2023cites this paper
• MicroRNA expression in extracellular vesicles as a novel blood-based biomarker for Alzheimer’s disease

  2023cites this paper
• Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s Disease

  2023cites this paper
• Astrocytic transcription factors REST, YY1, and putative microRNAs in Parkinson's disease and advanced therapeutic strategies.

  2023cites this paper
• Exploration of the Noncoding Genome for Human-Specific Therapeutic Targets—Recent Insights at Molecular and Cellular Level

  2023cites this paper
• Epigenetic regulons in Alzheimer's disease.

  2023cites this paper
• Lowering Hippocampal miR-29a Expression Slows Cognitive Decline and Reduces Beta-Amyloid Deposition in 5×FAD Mice

  2023cites this paper
• Small RNA Profiles of Brain Tissue-Derived Extracellular Vesicles in Alzheimer’s Disease

  2023cites this paper
• Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer's disease.

  2023cites this paper
• Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature

  2023influential citation
• Brain microRNAs are associated with variation in cognitive trajectory in advanced age

  2022cites this paper
• Danhong injection alleviates cerebral ischemia-reperfusion injury by inhibiting autophagy through miRNA-132-3p/ATG12 signal axis.

  2022cites this paper
• The role of microRNAs in neurodegenerative diseases: a review

  2022cites this paper
• MicroRNAs in Learning and Memory and Their Impact on Alzheimer’s Disease

  2022cites this paper
• Insights into the mechanisms of non-coding RNAs’ implication in the pathogenesis of Alzheimer’s disease

  2022cites this paper
• Progress in research on the role of exosomal miRNAs in the diagnosis and treatment of cardiovascular diseases

  2022cites this paper
• Small Molecule Inducers of Neuroprotective miR-132 Identified by HTS-HTS in Human iPSC-derived Neurons

  2022cites this paper
• Identification of potential therapeutic and diagnostic characteristics of Alzheimer disease by targeting the miR-132-3p/FOXO3a-PPM1F axis in APP/PS1 mice.

  2022cites this paper
• Expression relationship and significance of NEAT1 and miR-27a-3p in serum and cerebrospinal fluid of patients with Alzheimer’s disease

  2022cites this paper
• Biomarkers of Frailty: miRNAs as Common Signatures of Impairment in Cognitive and Physical Domains

  2022cites this paper
• MicroRNA modulation is a potential molecular mechanism for neuroprotective effects of intranasal insulin administration in amyloid βeta oligomer induced Alzheimer's like rat model.

  2022cites this paper
• Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases

  2022cites this paper
• Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey

  2022influential citation
• Exercise Training Improves Memory Performance in Older Adults: A Narrative Review of Evidence and Possible Mechanisms

  2022cites this paper
• Regulation of microRNAs in Alzheimer´s disease, type 2 diabetes, and aerobic exercise training

  2022cites this paper
• MiRNA-based Signature to Predict the Development of Alzheimer's Disease.

  2022cites this paper
• ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies

  2022cites this paper
• Non-Coding RNAs in the Regulation of Hippocampal Neurogenesis and Potential Treatment Targets for Related Disorders

  2022cites this paper
• The Role of Epigenetics in Neuroinflammatory-Driven Diseases

  2022cites this paper
• miR-212-3p attenuates neuroinflammation of rats with Alzheimer’s disease via regulating the SP1/BACE1/NLRP3/Caspase-1 signaling pathway

  2022cites this paper
• A novel approach to type 3 diabetes mechanism: The interplay between noncoding RNAs and insulin signaling pathway in Alzheimer's disease

  2022cites this paper
• Role of microRNA in Endocrine Disruptor-Induced Immunomodulation of Metabolic Health

  2022cites this paper
• Co-Expression Analysis of microRNAs and Proteins in Brain of Alzheimer’s Disease Patients

  2022cites this paper
• The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives

  2021cites this paper
• Antisense oligonucleotides for Alzheimer's disease therapy: from the mRNA to miRNA paradigm

  2021cites this paper
• Analysis of Serum miRNAs in Alzheimer’s Disease

  2021cites this paper
• Neurotransmitter-stimulated neuron-derived sEVs have opposite effects on amyloid β-induced neuronal damage

  2021cites this paper